Quick answer: Morgan Stanley (NYSE: MS) shares price reached back to about $198-$205 at the end of September 2026, following a summer peak near $218, after a series of financial-sector sell-offs and a new capital-markets deal that sent some short-term traders. The shares are up considerably for the year. Wall Street analysts have a consensus rating of “Moderate Buy” with averages of prices targets well above the current price. The next big test for Morgan Stanley will be the firm’s Q3 2026 earnings report on 14 October 2026.
Morgan Stanley Stock at a Glance
Here’s the snapshot most people search for first. Prices move every trading day, so treat these as a late-September 2026 reference point, not a live quote – check your brokerage app or a site like Yahoo Finance for the exact number right now.
| Ticker | NYSE: MS |
| Recent share price (Sept 2026) | Roughly $198-$205, pulled back from a summer high near $218 |
| 52-week range | About $151.84 to $232.25 |
| Market capitalisation | Roughly $315-$320 billion |
| Dividend yield | Around 1.9%-2.0% |
| Consensus analyst rating | Moderate Buy |
| Average price target | Around $224, with Bank of America at $250 |
| Next earnings date | 14 October 2026 (Q3 2026 results) |
| Consensus EPS estimate | $3.13 per share |
| Consensus revenue estimate | $20.36 billion |
What’s Happening With Morgan Stanley Stock Right Now?
Morgan Stanley reported an impressive 1H2026, with the share price climbing from the lows of $150s toward $218 set in early September on the back of robust trading and wealth-management revenue. But then the bulls grew complacent, and the bears capitalized on the opportunity. The shares sold off sharply by more than 5% in a single week in mid-September, and, as of 18 September, they were down nearly 7% for the month, although they were still up 16% year-to-date.
The weakness persisted through the last week of September. On 22 September 2026, Morgan Stanley stock closed nearly 3% lower after a rough week, with the shares trading near the $198-$200 level. The catalysts for the recent sell-off were not necessarily shocking news related to Morgan Stanley. Some analysts on CNBC noted a deeper concern about the longer-term implications of AI agents taking over financial services, but there were also broader bank-stock weakness and the announcement that Morgan Stanley would join the underwriting group for a $720 million tech IPO, which is a short-term negative for the bank’s finances.
and automated “cash sorting” tools could squeeze the fees brokerages earn from parking client cash, a theme now weighing on the whole retail-brokerage sector, not just Morgan Stanley.
Adding to the cautious mood, Morgan Stanley’s own chief investment strategist, Michael Wilson, warned that tighter financial conditions or a jump in energy prices could send the broader S&P 500 down as much as 7%. When a bank’s own strategist is flagging market risk, it’s worth paying attention – even if it’s not a call on the bank’s own stock specifically.
Why Did Morgan Stanley Shares Pull Back This Month?
Three things are driving the recent dip, and none of them point to a problem unique to Morgan Stanley:
Sector-wide rotation. While financial stocks generally cooled off in September, parts of the tech-heavy Nasdaq continued to climb, so Morgan Stanley fell short of the index on both days in dollar terms.
New deal exposure. Underwriting the Accelevation IPO exposes new capital risks before the issue prices, which markets read as a market short-term negative.
Macro jitters. Concerns about tightening financial conditions, energy-price risk, and possible market corrections have made investors more willing to sell bank shares first and ask questions later after the release of the latest report.
None of this has changed the core business fundamentals. July’s reported EPS came in at $3.46, ahead of what many were expecting at this time of year, and the firm’s wealth-management division – its most stable, fee-based business – has continued to grow.
What Do Analysts Say About Morgan Stanley’s Outlook?
The Wall Street consensus rating is a “Moderate Buy,” based on an abundance of strong buy, buy and hold recommendations, with just a handful of sells. Average 12-month price targets are well above the current share price, and Bank of America kept a $250 target even after the recent pullback. That reflects analysts’ views that the slide was just a correction within a broader uptrend.
But a target is a moving opinion. Analysts always update their targets, in reaction to all sorts of factors that the banks’ stock may encounter. Interest-rate decisions, volume of deals on Wall Street and the amount of trading business funneled through Morgan Stanley’s markets division can all affect a bank’s stock price.
What’s Next: The October Earnings Date
Morgan Stanley, a multinational investment bank, is set to report its Q3 2026 earnings on 14 October 2026. The projected results are around $3.13 per share on revenue of $20.36 billion, according to consensus estimates. The report will be more meaningful than any particular day’s price changes since it will indicate whether the wealth-management and trading divisions continued to thrive in a more turbulent September and if the fears about AI-powered cash sorting would affect the figures or appear to be merely speculative.
Should You Invest in Morgan Stanley Stock?
This isn’t financial advice – Claude and this article aren’t a substitute for a licensed financial adviser – but here’s a simple way to weigh what’s in front of you right now.
Reasons some investors like it
- Diversified income: investment banking, trading and wealth management all contribute, so one weak quarter in one division doesn’t sink the whole result.
- Consensus rating remains Moderate Buy, with most price targets above the current share price.
- Still up double digits for 2026 even after the September pullback.
Reasons for caution
- Bank stocks are sensitive to interest-rate moves and broader market swings you can’t control.
- The AI-driven cash-sorting trend is a real, still-developing risk to brokerage revenue.
- Recent underwriting deals add short-term balance-sheet exposure until they close.
A sensible middle ground many investors use: wait for the 14 October earnings report before deciding whether the September dip was a buying opportunity or the start of something longer.
Key Risks to Watch
- Interest rate changes from the Federal Reserve, which affect bank lending margins and trading revenue.
- A broader market correction – Morgan Stanley’s own strategist has flagged this as a real possibility.
- Regulatory or legal costs, which have hit large US banks before.
- Slower deal-making activity, which would reduce investment-banking fees.
Frequently Asked Questions
Is Morgan Stanley stock a good buy right now?
Wall Street’s consensus rating is Moderate Buy, and most analyst price targets sit above the current share price. That said, the stock has been volatile in September 2026, and many investors are waiting for the 14 October 2026 earnings report before adding to a position.
Why did Morgan Stanley stock drop in September 2026?
Shares fell mainly because of sector-wide bank-stock weakness, new underwriting exposure from a $720 million IPO deal, and growing concern that AI-driven “cash sorting” tools could reduce fee income across the brokerage industry – not because of bad news from Morgan Stanley itself.
What is Morgan Stanley’s 52-week stock price range?
As of late September 2026, Morgan Stanley shares have traded between roughly $151.84 and $232.25 over the past year.
When does Morgan Stanley report earnings next?
Morgan Stanley’s next earnings report is scheduled for 14 October 2026, covering Q3 2026, with consensus estimates of $3.13 earnings per share and $20.36 billion in revenue.
Does Morgan Stanley pay a dividend?
Yes. Morgan Stanley pays a quarterly dividend, with a yield of roughly 1.9%-2.0% at current share price levels.
Is Morgan Stanley stock the same as Morgan Stanley the bank?
Yes. Morgan Stanley trades on the New York Stock Exchange under the ticker MS, and the share price reflects investor sentiment about the whole business: investment banking, trading, and wealth management combined.
The Bottom Line
Morgan Stanley is one of Wall Street’s largest and most diversified banks. Most analysts continue to recommend the stock as a buy despite its recent setback in September. Shares have been particularly volatile this month, with a combination of sector rotations and a new deal rather than a deterioration in the fundamentals. If you’re thinking about buying this stock, the next crucial piece of information to watch for is the earnings report on 14 October, as everything before that is simply market noise on a fundamentally positive stock.
